Modification of interferon level in leucocytes of patients with morbus Hodgkin
Busse, E.; Rose, H.
Archiv für Geschwulstforschung 50(7): 672-675
1980
ISSN/ISBN: 0003-911X PMID: 6165334 Document Number: 166802
The interferon level in leukocytes of patients with Morbus Hodgkin were measured in the acute phase as in the remissions phase. A high decrease of interferon level has been observed by patients in the acute phase in comparison to controls. During the remissions phase the decrease has been low. There is no dependence to histological type or clinical stage.
Document emailed within 1 workday
Related Documents
Panchenko, L.F.; Terebilina, N.N.; Malinovskaia, V.V.; Manakhova, L.S.; Petrichenko, O.B.; Balashov, A.M. 1990: Modification by alpha-interferon of ethanol-induced changes in the level of opioid peptides in the rat striatum and hypophysis Voprosy Meditsinskoi Khimii 36(3): 71-73Khesin, Y.E.; Voronina, F.V.; Amchenkova, A.M. 1970: Morphological and histochemical studies on cultures of mouse peritoneal leucocytes during interferon formation Acta Virologica 14(6): 445-452
Lenti, G. 1974: "Morbus diabeticus". Etiopathogenesis--clinical classification: under the term Morbus diabeticus (M.d) Münchener Medizinische Wochenschrift 116(25): 1243-1252
Shakeel Ahmad, J.; Ashfaa, A.; Habib Ahmad, J. 2014: Effect of standard interferon and ribavirin on haemoglobin level in hepatitis-C patients Journal of Ayub Medical College Abbottabad: Jamc 26(4): 510-512
Jelliffe, A.M. 1973: Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease National Cancer Institute Monograph 36: 325-326
Xiao, Y.; Kong, X.-b.; Chen, J.-y.; Ruan, Y. 2013: Relationship between recurrent spontaneous abortion and the level of interferon-γ and interleukin-4 in peripheral blood and gingival crevicular fluid of patients with chronic periodontitis Zhonghua Kou Qiang Yi Xue Za Zhi 48(3): 150-154
Palumbo, A.P.; Garino, A.L.; Frieri, R.; Gallone, G.; Boccadoro, M.; Pileri, A. 1990: Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy Haematologica 75(6): 576-578
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Kelényi, G.; Németh, A. 1972: Tissue eosinophil leucocytes. II. Electron microscopy and histochemistry of the uterine eosinophil leucocytes in oestrogen-treated spayed rats Acta Biologica Academiae Scientiarum Hungaricae 23(3): 253-267
Peter, E. 1975: A double blind comparison of naproxen and indomethacin on the after-midnight-pain of patients with morbus bechterew Arzneimittel-Forschung 25(2a): 324-325
Miglino, M.; Pierri, I.; Canepa, L.; Carrara, P.; Celesti, L.; Gobbi, M. 1993: An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma Haematologica 78(6): 411-413
Levy, S.; Reins, F.; Aleksijevic, A.; Giron, C.; Oberling, F.; Mayer, S.; Lang, J.M. 1986: Interferon enhanced natural killer function in Hodgkin's disease Nouvelle Revue Francaise d'Hematologie 28(5): 323-325
Purcell, R.H.; London, W.T.; McAuliffe, V.J.; Palmer, A.E.; Kaplan, P.M.; Gerin, J.L.; Wagner, J.; Popper, H.; Lvovsky, E.; Wong, D.C.; Levy, H.B. 1976: Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer Lancet 2(7989): 757-761
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Krown, S.E.; Mintzer, D.; Cunningham-Rundles, S.; Niedzwiecki, D.; Krim, M.; Einzig, A.I.; Gabrilove, J.L.; Shurgot, B.; Gessula, J. 1987: High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses Cancer Treatment Reports 71(1): 39-45
Sattler, R.W.; Schmitz, T.; van Zwieten, P.A. 1971: Modification of plasma digitalis level by volume substitution Der Anaesthesist 20(9): 354-356
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Grigorian, S.S.; Pritsker, A.D.; Onufrieva, E.K.; Chireshkin, D.G.; Ershov, F.I. 1991: The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis Voprosy Virusologii 36(5): 407-409
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130